BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25253937)

  • 1. Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies.
    Herzer K; Gerken G; Hofmann TG
    World J Gastroenterol; 2014 Sep; 20(35):12367-71. PubMed ID: 25253937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL; Wu ML
    J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.
    Yamaguchi T; Yoshida K; Murata M; Matsuzaki K
    World J Gastroenterol; 2014 Sep; 20(35):12381-90. PubMed ID: 25253939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
    Yamashita T; Honda M; Kaneko S
    J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice.
    Herzer K; Carbow A; Sydor S; Sowa JP; Biesterfeld S; Hofmann TG; Galle PR; Gerken G; Canbay A
    PLoS One; 2012; 7(9):e44474. PubMed ID: 22984515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
    Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
    PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
    Reineke EL; Kao HY
    Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
    Wong MT; Chen SS
    Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis.
    Yoon GS; Yu E
    J Korean Med Sci; 2001 Aug; 16(4):433-8. PubMed ID: 11511788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
    Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
    mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma.
    Xia M; Zhang JQ; Shen YQ; Xu LH; Chen AQ; Miao FQ; Xie W
    Tissue Antigens; 2007 Oct; 70(4):272-82. PubMed ID: 17767548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues.
    Chan JY; Chin W; Liew CT; Chang KS; Johnson PJ
    Eur J Cancer; 1998 Jun; 34(7):1015-22. PubMed ID: 9849449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?
    Rusyn I; Lemon SM
    Cancer Lett; 2014 Apr; 345(2):210-5. PubMed ID: 23871966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice.
    Straub K; Husen P; Baba HA; Trippler M; Wedemeyer H; Herzer K
    Cancer Med; 2019 Jul; 8(8):3793-3802. PubMed ID: 31144474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma.
    Huang T; Liu L; Liu Q; Ding G; Tan Y; Tu Z; Li Y; Dai H; Xie L
    Int J Comput Biol Drug Des; 2011; 4(1):5-18. PubMed ID: 21330691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual oncogenic and tumor suppressor roles of the promyelocytic leukemia gene in hepatocarcinogenesis associated with hepatitis B virus surface antigen.
    Chung YL; Wu ML
    Oncotarget; 2016 May; 7(19):28393-407. PubMed ID: 27058621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.